Table 2.
Variables | N (%) | Univariate analysis | |
---|---|---|---|
5-year OS (%) | P-value | ||
Age, years | < 0.001 | ||
≤ 65 | 26,305 (46.4) | 85.3 | |
> 65 | 30,442 (53.6) | 72.6 | |
Gender | 0.353 | ||
Male | 27,507 (48.5) | 78.5 | |
Female | 29,240 (51.5) | 78.7 | |
Tumor location | 0.763 | ||
Rectum | 10,613 (18.7) | 78.3 | |
Colon | 46,134 (81.3) | 78.5 | |
Histologic grade | < 0.001 | ||
Well differentiated | 5,382 (9.5) | 87.6 | |
Moderately differentiated | 41,004 (72.3) | 80.2 | |
Poorly differentiated | 9,609 (16.9) | 66.9 | |
Undifferentiated | 752 (1.3) | 65.4 | |
Tumor size, cm | < 0.001 | ||
≤ 5 | 35,672 (62.9) | 80.6 | |
> 5 | 16,259 (28.7) | 72.2 | |
Unknown | 4,816 (8.5) | 85.6 | |
AJCC 8th T stage | < 0.001 | ||
pT1 | 8,022 (14.1) | 95.5 | |
pT2 | 9,957 (17.5) | 91.6 | |
pT3 | 32,726 (57.7) | 75.7 | |
pT4 | 6,042 (10.7) | 51.6 | |
NDLN | < 0.001 | ||
Inadequate (n < 12) | 16,699 (29.4) | 76.2 | |
Adequate (n ≥ 12) | 40,048 (70.6) | 79.7 |
N, number; OS, overall survival rate; NDLN, the number of dissected lymph nodes; AJCC, American Joint Committee on Cancer.